Visgeneer Total Liabilities

Latest as of June 2026: NT$130.36 Million TWD ≈ $4.11 Million USD

Visgeneer total liabilities. Based on the latest financial reports, Visgeneer (4197) has total liabilities worth NT$130.36 Million TWD (≈ $4.11 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Visgeneer to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Visgeneer (2011–2025)

Total liabilities of Visgeneer from 2011 to 2025. This chart illustrates how Visgeneer's total liabilities have evolved over time, based on quarterly financial data.

Visgeneer Competitors by Total Liabilities

The table below lists competitors of Visgeneer ranked by their total liabilities.

Company Country Total Liabilities
PRS Reit PLC
LSE:PRSR
UK GBX442.94 Million
Adelong Gold Ltd
AU:ADG
Australia AU$702.45K
Muza S.A
WAR:MZA
Poland zł18.80 Million
DXN Ltd
AU:DXN
Australia AU$10.91 Million
WALKER RIVER RES CORP
F:1WV0
Germany €562.04K
Axolot Solutions Holding AB
ST:AXOLOT
Sweden Skr4.00 Million
Ekiz Kimya Sanayi ve Ticaret AS
IS:EKIZ
Turkey TL37.32 Million
CYL Corporation Bhd
KLSE:7157
Malaysia RM19.44 Million

Liability Composition Analysis (2011–2025)

This chart breaks down Visgeneer's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 4197 current and non-current assets.

Liquidity & Leverage Metrics

Visgeneer Total Liabilities Ratios Explained

Visgeneer total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 3.45 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.68 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.40 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Visgeneer's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Visgeneer (2011–2025)

The table below shows the annual total liabilities of Visgeneer from 2011 to 2025.

Year Total Liabilities Change
2025-12-31 NT$135.94 Million
≈ $4.28 Million
-1.67%
2024-12-31 NT$138.25 Million
≈ $4.36 Million
-25.51%
2023-12-31 NT$185.60 Million
≈ $5.85 Million
-27.38%
2022-12-31 NT$255.58 Million
≈ $8.05 Million
+22.74%
2021-12-31 NT$208.23 Million
≈ $6.56 Million
-14.65%
2020-12-31 NT$243.97 Million
≈ $7.69 Million
-7.37%
2019-12-31 NT$263.37 Million
≈ $8.30 Million
+30.32%
2018-12-31 NT$202.09 Million
≈ $6.37 Million
-24.20%
2017-12-31 NT$266.61 Million
≈ $8.40 Million
+28.32%
2016-12-31 NT$207.76 Million
≈ $6.55 Million
-7.10%
2015-12-31 NT$223.64 Million
≈ $7.05 Million
+218.59%
2014-12-31 NT$70.20 Million
≈ $2.21 Million
+50.02%
2013-12-31 NT$46.79 Million
≈ $1.47 Million
+45.00%
2012-12-31 NT$32.27 Million
≈ $1.02 Million
+21.13%
2011-12-31 NT$26.64 Million
≈ $839.34K
--

About Visgeneer

TWO:4197 Taiwan Biotechnology
Market Cap
$7.54 Million
NT$239.34 Million TWD
Market Cap Rank
#27604 Global
#1586 in Taiwan
Share Price
NT$7.93
Change (1 day)
-3.29%
52-Week Range
NT$7.93 - NT$19.00
All Time High
NT$28.80
About

Visgeneer Inc. engages in the provision of health solutions in the fields of medical device, cosmetics and skin care, Zeaxanthin, and cancer gene diagnostics in Europe and Asia. The company offers blood glucose and ketone, uric acid, and cholesterol monitoring systems. It also provides functional masks, such as wood pulp mask, invisible mask, black mask, pure cloth mask, and bio cellulose mask; f… Read more